Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas S Heitmann

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|October 29, 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patientsSusanne Jung, Annika Nelde, Yacine Maringer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2023
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancersLatifa Zekri, Martina Lutz, Nisha Prakash, et al.
Frontiers in Oncology|September 10, 2024
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimensAlexander Englisch, Clara Hayn, Susanne Jung, et al.
European Journal of Immunology|August 23, 2021
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector functionFabian Brunk, Andreas Moritz, Annika Nelde, et al.
Iscience|November 28, 2022
Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunityAnnika Nelde, Jonas Rieth, Malte Roerden, et al.
Frontiers in Immunology|July 26, 2021
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic LeukemiaAnnika Nelde, Yacine Maringer, Tatjana Bilich, et al.
Science Translational Medicine|March 16, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individualsTatjana Bilich, Annika Nelde, Jonas S Heitmann, et al.
Frontiers in Oncology|April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusionChristopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
International Journal of Molecular Sciences|April 13, 2024
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease OutcomeAnna Seller, Christian M Tegeler, Jonas Mauermann, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy developmentSteffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|October 29, 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patientsSusanne Jung, Annika Nelde, Yacine Maringer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2023
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancersLatifa Zekri, Martina Lutz, Nisha Prakash, et al.
Frontiers in Oncology|September 10, 2024
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimensAlexander Englisch, Clara Hayn, Susanne Jung, et al.
European Journal of Immunology|August 23, 2021
SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector functionFabian Brunk, Andreas Moritz, Annika Nelde, et al.
Iscience|November 28, 2022
Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunityAnnika Nelde, Jonas Rieth, Malte Roerden, et al.
Frontiers in Immunology|July 26, 2021
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic LeukemiaAnnika Nelde, Yacine Maringer, Tatjana Bilich, et al.
Science Translational Medicine|March 16, 2021
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individualsTatjana Bilich, Annika Nelde, Jonas S Heitmann, et al.
Frontiers in Oncology|April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusionChristopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
International Journal of Molecular Sciences|April 13, 2024
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease OutcomeAnna Seller, Christian M Tegeler, Jonas Mauermann, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy developmentSteffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, et al.
Pageof 7